BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 26941826)

  • 1. Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective.
    Tan HY; San-Marina S; Wang N; Hong M; Li S; Li L; Cheung F; Wen XY; Feng Y
    Evid Based Complement Alternat Med; 2016; 2016():4750163. PubMed ID: 26941826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herbal remedies for liver fibrosis: A review on the mode of action of fifty herbs.
    Latief U; Ahmad R
    J Tradit Complement Med; 2018 Jul; 8(3):352-360. PubMed ID: 29992106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herbal medicines for fatty liver diseases.
    Liu ZL; Xie LZ; Zhu J; Li GQ; Grant SJ; Liu JP
    Cochrane Database Syst Rev; 2013 Aug; (8):CD009059. PubMed ID: 23975682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic profiles of anticancer herbal medicines in humans and the clinical implications.
    Chen XW; Sneed KB; Zhou SF
    Curr Med Chem; 2011; 18(21):3190-210. PubMed ID: 21671861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Network-Based Pharmacology Study of the Herb-Induced Liver Injury Potential of Traditional Hepatoprotective Chinese Herbal Medicines.
    Hong M; Li S; Tan HY; Cheung F; Wang N; Huang J; Feng Y
    Molecules; 2017 Apr; 22(4):. PubMed ID: 28420096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects.
    Hong M; Li S; Tan HY; Wang N; Tsao SW; Feng Y
    Int J Mol Sci; 2015 Dec; 16(12):28705-45. PubMed ID: 26633388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADME properties of herbal medicines in humans: evidence, challenges and strategies.
    He SM; Chan E; Zhou SF
    Curr Pharm Des; 2011; 17(4):357-407. PubMed ID: 21385154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herbal medicines for the prevention of alcoholic liver disease: a review.
    Ding RB; Tian K; Huang LL; He CW; Jiang Y; Wang YT; Wan JB
    J Ethnopharmacol; 2012 Dec; 144(3):457-65. PubMed ID: 23058988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herbal medicines and nonalcoholic fatty liver disease.
    Yao H; Qiao YJ; Zhao YL; Tao XF; Xu LN; Yin LH; Qi Y; Peng JY
    World J Gastroenterol; 2016 Aug; 22(30):6890-905. PubMed ID: 27570425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological analysis of herbal medicines used for the treatment of liver diseases.
    Chien CF; Wu YT; Tsai TH
    Biomed Chromatogr; 2011 Jan; 25(1-2):21-38. PubMed ID: 21204110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between Transporters and Herbal Medicines/Drugs: A Focus on Hepatoprotective Compounds.
    Zhang A; Li Q; He X; Si D; Liu C
    Curr Drug Metab; 2015; 16(10):911-8. PubMed ID: 26264198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel strategy of profiling the mechanism of herbal medicines by combining network pharmacology with plasma concentration determination and affinity constant measurement.
    Chen L; Lv D; Wang D; Chen X; Zhu Z; Cao Y; Chai Y
    Mol Biosyst; 2016 Oct; 12(11):3347-3356. PubMed ID: 27754507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition pathways and pharmacokinetics of herbal medicines in humans.
    He SM; Li CG; Liu JP; Chan E; Duan W; Zhou SF
    Curr Med Chem; 2010; 17(33):4072-113. PubMed ID: 20939821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herbal medicines for liver diseases in India.
    Thyagarajan SP; Jayaram S; Gopalakrishnan V; Hari R; Jeyakumar P; Sripathi MS
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl 3():S370-6. PubMed ID: 12472966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Hepatic Stellate Cells for the Treatment of Liver Fibrosis by Natural Products: Is It the Dawning of a New Era?
    Chan YT; Wang N; Tan HY; Li S; Feng Y
    Front Pharmacol; 2020; 11():548. PubMed ID: 32425789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress on anti-liver fibrosis candidates in patents of herbal medicinal products.
    Wang XB; Feng Y; Wang N; Cheung F; Wong CW
    Recent Pat Food Nutr Agric; 2012 Aug; 4(2):91-106. PubMed ID: 22594662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herbal Induced Hepatoprotection and Hepatotoxicity: A Critical Review.
    Bedi O; Bijjem KRV; Kumar P; Gauttam V
    Indian J Physiol Pharmacol; 2016; 60(1):6-21. PubMed ID: 29953177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatoprotective properties of extensively studied medicinal plant active constituents: possible common mechanisms.
    Farghali H; Canová NK; Zakhari S
    Pharm Biol; 2015 Jun; 53(6):781-91. PubMed ID: 25489628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Liver toxicity of drugs of plant origin].
    Stickel F; Seitz HK; Hahn EG; Schuppan D
    Z Gastroenterol; 2001 Mar; 39(3):225-32, 234-7. PubMed ID: 11324140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in herbal medicine for treatment of liver diseases.
    Ghosh N; Ghosh R; Mandal V; Mandal SC
    Pharm Biol; 2011 Sep; 49(9):970-88. PubMed ID: 21595500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.